In humans, heterozygous loss-of-function variants in NSD1 increase skeletal growth in Sotos syndrome, whereas, in mice, homozygous loss of Nsd1 impairs skeletal growth, in part by regulating Sox9 expression in chondrocytes (27). The gene discussed is SOX9; the disease is Sotos syndrome.